GB202114794D0 - Compositions of high viscosity - Google Patents

Compositions of high viscosity

Info

Publication number
GB202114794D0
GB202114794D0 GBGB2114794.7A GB202114794A GB202114794D0 GB 202114794 D0 GB202114794 D0 GB 202114794D0 GB 202114794 A GB202114794 A GB 202114794A GB 202114794 D0 GB202114794 D0 GB 202114794D0
Authority
GB
United Kingdom
Prior art keywords
compositions
high viscosity
viscosity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB2114794.7A
Other versions
GB2611803A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nasaleze Patents Ltd
Original Assignee
Nasaleze Patents Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nasaleze Patents Ltd filed Critical Nasaleze Patents Ltd
Priority to GB2114794.7A priority Critical patent/GB2611803A/en
Publication of GB202114794D0 publication Critical patent/GB202114794D0/en
Priority to PCT/GB2022/052565 priority patent/WO2023062349A1/en
Publication of GB2611803A publication Critical patent/GB2611803A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/84—Valerianaceae (Valerian family), e.g. valerian
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/148—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
GB2114794.7A 2021-10-15 2021-10-15 Compositions of high viscosity Withdrawn GB2611803A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB2114794.7A GB2611803A (en) 2021-10-15 2021-10-15 Compositions of high viscosity
PCT/GB2022/052565 WO2023062349A1 (en) 2021-10-15 2022-10-10 Compositions of high viscosity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2114794.7A GB2611803A (en) 2021-10-15 2021-10-15 Compositions of high viscosity

Publications (2)

Publication Number Publication Date
GB202114794D0 true GB202114794D0 (en) 2021-12-01
GB2611803A GB2611803A (en) 2023-04-19

Family

ID=78718502

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2114794.7A Withdrawn GB2611803A (en) 2021-10-15 2021-10-15 Compositions of high viscosity

Country Status (2)

Country Link
GB (1) GB2611803A (en)
WO (1) WO2023062349A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1368090B1 (en) 2001-02-08 2007-04-11 Nasaleze Patents Limited Apparatus for dispensing powdered material
US8202550B2 (en) 2004-10-11 2012-06-19 Nasaleze Ppm Limited Compositions for intranasal administration
EP3183022B1 (en) 2014-08-20 2019-09-04 Nasaleze Patents Ltd Dispensing apparatus
EP3154515B1 (en) 2014-06-10 2021-04-28 Nasaleze Patents Limited Improvements to nasal compositions and method of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202001906D0 (en) * 2020-02-12 2020-03-25 Nasaleze Patents Ltd Compositions And Applications Thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1368090B1 (en) 2001-02-08 2007-04-11 Nasaleze Patents Limited Apparatus for dispensing powdered material
US8202550B2 (en) 2004-10-11 2012-06-19 Nasaleze Ppm Limited Compositions for intranasal administration
EP3154515B1 (en) 2014-06-10 2021-04-28 Nasaleze Patents Limited Improvements to nasal compositions and method of use thereof
EP3183022B1 (en) 2014-08-20 2019-09-04 Nasaleze Patents Ltd Dispensing apparatus

Non-Patent Citations (20)

* Cited by examiner, † Cited by third party
Title
COLE, E. C.COOK, C. E.: "Characterization of infectious aerosols in health care facilities: an aid to effective engineering controls and preventive strategies", AM J INFECT CONTROL, vol. 26, no. 4, 1998, pages 453 - 64, XP005697684, DOI: 10.1016/S0196-6553(98)70046-X
FENNELLY, K. P.: "Particle sizes of infectious aerosols: implications for infection control", LANCET RESPIR MED, vol. 8, no. 9, 2020, pages 914 - 924
HAN, Z. Y.WENG, W. G.HUANG, Q. Y.: "Characterizations of particle size distribution of the droplets exhaled by sneeze", J R SOC INTERFACE, vol. 10, no. 88, 2013, pages 20130560
HEMILA, H.CHALKER, E: "Carrageenan nasal spray may double the rate of recovery from coronavirus and influenza virus infections: Re-analysis of randomized trial data", PHARMACOL RES PERSPECT, vol. 9, no. 4, 2021, pages e00810
HUNT, N.SULEMAN, L.JOSLING, P. D.POPOV, T.: "Virucidal activity of Nasaleze Cold and Flu Blocker and Nasaleze Travel in cell cultures infected with human pathogenic coronavirus 229-E", BIORXIV, 2021
JANG, Y.SHIN, H.LEE, M. K.KWON, O. S.SHIN, J. S.KIM, Y. IKIM, C. WLEE, H. R.KIM, M.: "Antiviral activity of lambda-carrageenan against influenza viruses and severe acute respiratory syndrome coronavirus 2", SCI REP, vol. 11, no. 1, 2021, pages 821
LEIBBRANDT, A.MEIER, C.KONIG-SCHUSTER, MWEINMULLNER, R.KALTHOFF, D.PFLUGFELDER, B.GRAF, P.FRANK-GEHRKE, B.BEER, M.FAZEKAS, T.: "Iota-carrageenan is a potent inhibitor of influenza A virus infection", PLOS ONE, vol. 5, no. 12, 2010, pages e14320, XP009159153, DOI: 10.1371/journal.pone.0014320
MOAKES, R. J. A.DAVIES, S. P.STAMATAKI, Z.GROVER, L. M.: "Formulation of a Composite Nasal Spray Enabling Enhanced Surface Coverage and Prophylaxis of SARS-COV-2", ADV MATER, 2021, pages e2008304
MORAWSKA, L.CAO, J.: "Airborne transmission of SARS-CoV-2: The world should face the reality", ENVIRON INT, vol. 139, 2020, pages 105730, XP086155362, DOI: 10.1016/j.envint.2020.105730
MOROKUTTI-KURZ, M.FROBA, MGRAF, P.GROL3>E, M.GRASSAUER, A.AUTH, J.SCHUBERT, U.PRIESCHL-GRASSAUER, E.: "Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in vitro", PLOS ONE, vol. 16, no. 2, 2021, pages e0237480
POPOV T.A. ET AL., EXPERT REVIEW OF RESPIRATORY MEDICINE, vol. 11, no. 11, 2017, pages 885 - 892, Retrieved from the Internet <URL:https://doi.org/10.1080/17476348.2017.1375408>
POPOV, T. A.ABERG, N.EMBERLIN, J.JOSLING, P.ILYINA, N. I.NIKITIN, N. P.CHURCH, M.: "Methyl-cellulose powder for prevention and management of nasal symptoms", EXPERT REV RESPIR MED, vol. 11, no. 11, 2017, pages 885 - 892, XP055810278, DOI: 10.1080/17476348.2017.1375408
POPOV, T. A.EMBERLIN, J.JOSLING, P.SEIFALIAN, A.: "In vitro and in vivo Evaluation of the Efficacy and Safety of Powder Hydroxypropylmethylcellulose as Nasal Mucosal Barrier", MED DEVICES (AUCKL, vol. 13, 2020, pages 107 - 113, XP055804081, DOI: 10.2147/MDER.S236104
PROCTOR, D. F.LUNDQVIST, G.: "Clearance of inhaled particles from the human nose", ARCH INTERN MED, vol. 131, no. 1, 1973, pages 132 - 9
SCHUTZ, D.CONZELMANN, CFOIS, G.GROΒ, R.WEIL, T.WETTSTEIN, L.STENGER, S.ZELIKIN, A.HOFFMANN, T. K.FRICK, M.: "Carrageenan-containing over-the-counter nasal and oral sprays inhibit SARS-CoV-2 infection of airway epithelial cultures", AM J PHYSIOL LUNG CELL MOL PHYSIOL, vol. 320, no. 5, 2021, pages L750 - L756
STADNYTSKYI, V.BAX, C. E.BAX, A.ANFINRUD, P: "The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission", PROC NATL ACAD SCI USA, vol. 117, no. 22, 2020, pages 11875 - 11877
TELLIER, R.LI, YCOWLING, B. J.TANG, J. W.: "Recognition of aerosol transmission of infectious agents: a commentary", BMC INFECT DIS, vol. 19, no. 1, 2019, pages 101, XP021270762, DOI: 10.1186/s12879-019-3707-y
WINCHESTER, S.JOHN, S.JABBAR, K.JOHN, I.: "Clinical efficacy of nitric oxide nasal spray (NONS) for the treatment of mild COVID-19 infection", J INFECT, vol. 83, no. 2, 2021, pages 237 - 279, XP086703299, DOI: 10.1016/j.jinf.2021.05.009
ZHANG, R.LI, Y.ZHANG, A. L.WANG, Y.MOLINA, M. J.: "Identifying airborne transmission as the dominant route for the spread of COVID-19", PROC NATL ACAD SCI USA, vol. 117, no. 26, 2020, pages 14857 - 14863, XP055822961, DOI: 10.1073/pnas.2009637117
ZIA, K. M.TABASUM, S.NASIF, M.SULTAN, NASLAM, N.NOREEN, AZUBER, M.: "A review on synthesis, properties and applications of natural polymer based carrageenan blends and composites", INT J BIOL MACROMOL, vol. 96, 2017, pages 282 - 301, XP029886066, DOI: 10.1016/j.ijbiomac.2016.11.095

Also Published As

Publication number Publication date
GB2611803A (en) 2023-04-19
WO2023062349A1 (en) 2023-04-20

Similar Documents

Publication Publication Date Title
GB202013432D0 (en) Compositions
IL290324A (en) Compositions of trofinetide
IL304159A (en) Composition of bl-8040
GB202114794D0 (en) Compositions of high viscosity
GB202017863D0 (en) Novel compositions
GB202105461D0 (en) Compositions
GB202015836D0 (en) Compositions
IL312073A (en) Pharmaceutical compositions of efruxifermin
GB202019952D0 (en) Novel compositions
GB202114311D0 (en) New compositions
GB202012160D0 (en) New compositions
GB202012152D0 (en) New compositions
ZA202210764B (en) Compositions
GB202208611D0 (en) Compositions
GB202118081D0 (en) Compositions
GB202117074D0 (en) Compositions
GB202116861D0 (en) Compositions
GB202116386D0 (en) Compositions
GB202116387D0 (en) Compositions
GB202116388D0 (en) Compositions
GB202115617D0 (en) Compositions
GB202114053D0 (en) Compositions
GB202111897D0 (en) Compositions
GB202109945D0 (en) Compositions
GB202109947D0 (en) Compositions

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)